MRNA Comptes : Analyse IA Moderna Inc



Comptes financiers

MRNA Financier

Moderna Inc

$52.88

-2.7%

$-1.46

À la fermeture : May 11, 16:00:00 GMT-4

$53.15

0.51%

$0.26

Post-Marché: May 11, 20:00:00 GMT-4

Aperçu Prévision Gagner Dividendes Comptes financiers

Statistiques clés

Clôture préc.

$54.35

Prix d'ouverture

$58.03

Plage de la journée

$51.39 - $59.48

Plage de 52 semaines

$22.28 - $59.55

Volume

23.8M

Volume moyen

10.1M

Rendement en dividend

BPA (TTM)

-7.26

Capitalisation boursière

$21.0B

Qu’est-ce que MRNA ?

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The company is headquartered in Cambridge, Massachusetts and currently employs 4,700 full-time employees. The company went IPO on 2018-12-07. The firm is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). The company is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. The Company’s diverse development pipeline consists of 44 therapeutic and vaccine programs, 11 of which are in late-stage development. Its commercial products include Spikevax (its COVID vaccine) and mRESVIA (its respiratory syncytial virus (RSV) vaccine). Additionally, it has achieved four positive Phase III data readouts for its COVID vaccine (mRNA-1283), its RSV vaccine for high-risk adults aged 18 to 59 (mRNA-1345), its seasonal flu+COVID vaccine (mRNA-1083), and its seasonal flu vaccine (mRNA-1010).

Fonctionnalités

Markets

News

Conditions d’utilisation Politique de confidentialité

Moderna Inc (MRNA) Financier

MRNA Financier

Moderna Inc

$52.88

-2.7%

$-1.46

À la fermeture : May 11, 16:00:00 GMT-4

$53.15

0.51%

$0.26

Post-Marché: May 11, 20:00:00 GMT-4

Aperçu Prévision Gagner Dividendes Comptes financiers

Statistiques clés

Clôture préc.

$54.35

Prix d'ouverture

$58.03

Plage de la journée

$51.39 - $59.48

Plage de 52 semaines

$22.28 - $59.55

Volume

23.8M

Volume moyen

10.1M

Rendement en dividend

BPA (TTM)

-7.26

Capitalisation boursière

$21.0B

Qu’est-ce que MRNA ?

Breakdown	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025
Revenus	2,225	389	678	1,016	142	108
Croissance des revenus (H/H)	-30%	260%	-30%	-45%	-41%	-35%
Coût des ventes	1,446	917	308	140	81	48
Bénéfice brut	779	-528	370	876	61	60
Vente, Général et Administration	979	173	308	268	230	212
Recherche et développement	2,925	649	775	801	700	856
Frais d'exploitation	3,904	822	1,083	1,069	930	1,068
Autres revenus (charges) non opérationnels	3	0	-2	-4	9	4
Bénéfice avant impôts	-3,138	-1,334	-799	-187	-818	-964
Charge d'impôt sur le revenu	56	9	27	13	7	7
Bénéfice net	-3,194	-1,343	-826	-200	-825	-971
Croissance du bénéfice net	-5%	38%	-26%	-1,638%	-36%	-17%
Actions en circulation (diluées)	395	395	392	390	388	386
Variation des actions (H-H)	2%	2%	1%	-2%	1%	1%
EPS (dilué)	-8.08	-3.4	-2.1	-0.51	-2.12	-2.51
Croissance du EPS	-7%	35%	-27%	-1,673%	-36%	-18%
Flux de trésorerie libre	-1,603	-692	891	-880	-922	-1,164
Flux de trésorerie libre par action	--	--	--	--	--	--
Marge brute	35.01%	-135.73%	54.57%	86.22%	42.95%	55.55%
Marge opérationnelle	-140.44%	-347.04%	-105.16%	-18.99%	-611.97%	-933.33%
Marge bénéficiaire	-143.55%	-345.24%	-121.82%	-19.68%	-580.98%	-899.07%
Marge du flux de trésorerie libre	-72.04%	-177.89%	131.41%	-86.61%	-649.29%	-1,077.77%
EBITDA	-2,890	-1,291	-646	-141	-812	-969
Marge EBITDA	-129.88%	-331.87%	-95.28%	-13.87%	-571.83%	-897.22%
D&A pour le résultat opérationnel	235	59	67	52	57	39
EBIT	-3,125	-1,350	-713	-193	-869	-1,008
Marge EBIT	-140.44%	-347.04%	-105.16%	-18.99%	-611.97%	-933.33%
Taux d'imposition effectif	-1.78%	-0.67%	-3.37%	-6.95%	-0.85%	-0.72%

Breakdown

TTM

03/31/2026

12/31/2025

09/30/2025

06/30/2025

03/31/2025

Revenus

2,225

389

678

1,016

142

108

Croissance des revenus (H/H)

-30%

260%

-30%

-45%

-41%

-35%

Coût des ventes

1,446

917

308

140

Bénéfice brut

779

-528

370

876

Vente, Général et Administration

979

173

308

268

230

212

Recherche et développement

2,925

649

775

801

700

856

Frais d'exploitation

3,904

822

1,083

1,069

930

1,068

Autres revenus (charges) non opérationnels

-2

-4

Bénéfice avant impôts

-3,138

-1,334

-799

-187

-818

-964

Charge d'impôt sur le revenu

Bénéfice net

-3,194

-1,343

-826

-200

-825

-971

Croissance du bénéfice net

-5%

38%

-26%

-1,638%

-36%

-17%

Actions en circulation (diluées)

395

392

390

388

386

Variation des actions (H-H)

-2%

EPS (dilué)

-8.08

-3.4

-2.1

-0.51

-2.12

-2.51

Croissance du EPS

-7%

35%

-27%

-1,673%

-36%

-18%

Flux de trésorerie libre

-1,603

-692

891

-880

-922

-1,164

Flux de trésorerie libre par action

Marge brute

35.01%

-135.73%

54.57%

86.22%

42.95%

55.55%

Marge opérationnelle

-140.44%

-347.04%

-105.16%

-18.99%

-611.97%

-933.33%

Marge bénéficiaire

-143.55%

-345.24%

-121.82%

-19.68%

-580.98%

-899.07%

Marge du flux de trésorerie libre

-72.04%

-177.89%

131.41%

-86.61%

-649.29%

-1,077.77%

EBITDA

-2,890

-1,291

-646

-141

-812

-969

Marge EBITDA

-129.88%

-331.87%

-95.28%

-13.87%

-571.83%

-897.22%

D&A pour le résultat opérationnel

235

EBIT

-3,125

-1,350

-713

-193

-869

-1,008

Marge EBIT

-140.44%

-347.04%

-105.16%

-18.99%

-611.97%

-933.33%

Taux d'imposition effectif

-1.78%

-0.67%

-3.37%

-6.95%

-0.85%

-0.72%

Follow-Up Questions

Moderna Inc의 주요 재무제표는 무엇인가요?



최신 재무제표(Form-10K)에 따르면, Moderna Inc의 총 자산은 $0이며, 순perte입니다.

MRNA의 주요 재무 비율은 무엇인가요?



Moderna Inc의 유동비율은 0이고, 순이익률은 0, 주당 매출은 $0입니다.

Moderna Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?



Actuellement, les données Moderna Inc ne sont pas disponibles.

Moderna Inc은 수익성이 있나요?



non, 최신 재무제표에 따르면 Moderna Inc의 순perte은 $0입니다.

Moderna Inc에 부채가 있나요?



non, Moderna Inc의 부채는 0입니다.

Moderna Inc의 발행 주식은 몇 주인가요?



Moderna Inc의 총 발행 주식은 0주입니다.

Moderna Inc (MRNA) Financier

Graphique du cours de l'action MRNA

Statistiques clés

Clôture préc.

Prix d'ouverture

Plage de la journée

Plage de 52 semaines

Volume

Volume moyen

Rendement en dividend

BPA (TTM)

Capitalisation boursière

Qu’est-ce que MRNA ?

Moderna Inc (MRNA) Financier

Graphique du cours de l'action MRNA

Statistiques clés

Clôture préc.

Prix d'ouverture

Plage de la journée

Plage de 52 semaines

Volume

Volume moyen

Rendement en dividend

BPA (TTM)

Capitalisation boursière

Qu’est-ce que MRNA ?

MRNA Revenu

Follow-Up Questions

Moderna Inc의 주요 재무제표는 무엇인가요?

MRNA의 주요 재무 비율은 무엇인가요?

Moderna Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?

Moderna Inc은 수익성이 있나요?

Moderna Inc에 부채가 있나요?

Moderna Inc의 발행 주식은 몇 주인가요?